Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • iSpecimen's Cash & Current Investments rose 5884.65% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 5884.65%. This contributed to the annual value of $1.9 million for FY2024, which is 6247.39% down from last year.
  • As of Q3 2025, iSpecimen's Cash & Current Investments stood at $2.8 million, which was up 5884.65% from $588775.0 recorded in Q2 2025.
  • iSpecimen's 5-year Cash & Current Investments high stood at $27.7 million for Q4 2021, and its period low was $588775.0 during Q2 2025.
  • Moreover, its 5-year median value for Cash & Current Investments was $6.9 million (2023), whereas its average is $9.9 million.
  • As far as peak fluctuations go, iSpecimen's Cash & Current Investments soared by 388600.66% in 2021, and later plummeted by 7680.68% in 2024.
  • iSpecimen's Cash & Current Investments (Quarter) stood at $27.7 million in 2021, then tumbled by 44.81% to $15.3 million in 2022, then plummeted by 67.3% to $5.0 million in 2023, then tumbled by 62.47% to $1.9 million in 2024, then soared by 48.14% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $588775.0 for Q2 2025, and $782563.0 during Q1 2025.